SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-004231
Filing Date
2022-03-21
Accepted
2022-03-21 16:15:51
Documents
12
Period of Report
2022-03-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lbph-20220317.htm   iXBRL 8-K 55926
  Complete submission text file 0000950170-22-004231.txt   187540

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lbph-20220317_lab.xml EX-101.LAB 18544
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lbph-20220317_pre.xml EX-101.PRE 12097
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lbph-20220317.xsd EX-101.SCH 2521
6 EXTRACTED XBRL INSTANCE DOCUMENT lbph-20220317_htm.xml XML 5114
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40192 | Film No.: 22755870
SIC: 2834 Pharmaceutical Preparations